Testing effectiveness (Phase 2)Study completedNCT02511886
What this trial is testing
A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder
Who this might be right for
Alcohol Use Disorder
Indivior Inc. 18